Inventor · disambiguated record
Ingemar Starke
Also filed as: STARKE INGEMAR
57 granted patents·25 pending applications·1,509 citations·filing 1992–2025
99Inventor score
Top patents by PatentIndex Score
82 records- 0199US11572350B1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2022·Granted Feb 7, 2023·17 cites·15 claims
- 0299US11267794B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Mar 8, 2022·21 cites·16 claims
- 0399US11180465B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Nov 23, 2021·25 cites·18 claims
- 0499US11111224B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Sep 7, 2021·30 cites·10 claims
- 0599US11014898B1Benzothiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted May 25, 2021·30 cites·25 claims
- 0698US12134606B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2023·Granted Nov 5, 2024·5 cites·19 claims
- 0798US11891368B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2022·Granted Feb 6, 2024·10 cites·17 claims
- 0898US11773071B2Benzothiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Oct 3, 2023·14 cites·15 claims
- 0998US11732006B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2021·Granted Aug 22, 2023·11 cites·10 claims
- 1098US11708340B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Jul 25, 2023·12 cites·17 claims
- 1198US11377429B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Jul 5, 2022·13 cites·5 claims
- 1298US11306064B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2020·Granted Apr 19, 2022·17 cites·21 claims
- 1398US11225466B2Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Jan 18, 2022·23 cites·20 claims
- 1498US10981952B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2020·Granted Apr 20, 2021·20 cites·12 claims
- 1598US10975045B2Benzothiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2020·Granted Apr 13, 2021·23 cites·9 claims
- 1698US10941127B2Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2020·Granted Mar 9, 2021·28 cites·14 claims
- 1798US10487111B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2018·Granted Nov 26, 2019·23 cites·10 claims
- 1898US10093697B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2017·Granted Oct 9, 2018·25 cites·8 claims
- 1998US10011633B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2017·Granted Jul 3, 2018·20 cites·7 claims
- 2098US10000528B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2017·Granted Jun 19, 2018·18 cites·8 claims
- 2198US9694018B1IBAT inhibitors for the treatment of liver diseaseALBIREO AB·Filed 2016·Granted Jul 4, 2017·47 cites·15 claims
- 2298US9688720B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2016·Granted Jun 27, 2017·27 cites·6 claims
- 2397US12202809B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2023·Granted Jan 21, 2025·4 cites·17 claims
- 2497US12187812B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2022·Granted Jan 7, 2025·3 cites·10 claims
- 2597US11603359B2Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2020·Granted Mar 14, 2023·11 cites·18 claims
- 2697US10793534B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2019·Granted Oct 6, 2020·21 cites·10 claims
- 2797US10221212B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2018·Granted Mar 5, 2019·11 cites·8 claims
- 2896US12060338B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Aug 13, 2024·5 cites·15 claims
- 2996US12024495B2Benzothiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Jul 2, 2024·5 cites·10 claims
- 3096US11261212B2IBAT inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2016·Granted Mar 1, 2022·17 cites·8 claims
- 3195US12187690B2Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2023·Granted Jan 7, 2025·4 cites·20 claims
- 3295US7125864B2Benzothiazepine derivatives for the treatment of hyperlipidemiaASTRAZENECA AB·Filed 2002·Granted Oct 24, 2006·86 cites·11 claims
- 3394US12365658B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2022·Granted Jul 22, 2025·2 cites·16 claims
- 3493US7238684B2Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing themASTRAZENECA AB·Filed 2003·Granted Jul 3, 2007·93 cites·12 claims
- 3593US7226943B2Benzothiepine ileal bile acid transport inhibitorsASTRAZENECA AB·Filed 2002·Granted Jun 5, 2007·80 cites·21 claims
- 3693US7192947B2Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditionsASTRAZENECA AB·Filed 2003·Granted Mar 20, 2007·74 cites·8 claims
- 3793US7192945B2Benzothiazepine derivativesASTRAZENECA AB·Filed 2001·Granted Mar 20, 2007·85 cites·18 claims
- 3893US7132416B2Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemiaASTRAZENECA AB·Filed 2002·Granted Nov 7, 2006·90 cites·15 claims
- 3993US2025326789A1Ibat inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2024·Application pending·0 cites
- 4092US7192946B2Benzothiazepine derivativesASTRAZENECA AB·Filed 2002·Granted Mar 20, 2007·87 cites·13 claims
- 4191US6906058B21,5-Benzothiazepines and their use as hypolipidaemicsASTRAZENECA AB·Filed 2001·Granted Jun 14, 2005·108 cites·12 claims
- 4289US8067584B2Benzothiazepine derivativesSTARKE INGEMAR·Filed 2004·Granted Nov 29, 2011·70 cites·5 claims
- 4386US2025387449A1Pharmaceutical combination comprising an ibat inhibitor and a bile acid binderALBIREO AB·Filed 2025·Application pending·0 cites
- 4485US2023330176A1Pharmaceutical combination comprising an ibat inhibitor and a bile acid binderALBIREO AB·Filed 2023·Application pending·0 cites
- 4584US2025333390A1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2024·Application pending·0 cites
- 4683US2025100983A1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2024·Application pending·0 cites
- 4779US7470678B2Diphenylazetidinone derivatives for treating disorders of the lipid metabolismASTRAZENECA AB·Filed 2003·Granted Dec 30, 2008·18 cites·37 claims
- 4879US2025019353A1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2024·Application pending·0 cites
- 4978US2020330545A1Pharmaceutical combination comprising an ibat inhibitor and a bile acid binderALBIREO AB·Filed 2019·Application pending·0 cites
- 5076US2015031636A1Ibat inhibitors for the treatment of liver diseasesALBIREO AB·Filed 2014·Application pending·0 cites
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ingemar Starke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →